Local rhBMP-2 injection after drill-hole injury in rats: Does it have systemic effects?

International Journal of Immunopathology and Pharmacology

Volumn 27, Issue 2, 2014, Pages 253-260

  Demirkan, N ^a   Demirkan, Ahmet Fahir ^a   Aksoy, A ^b   Ozdemir M ^c   Akman, A ^a  

^a PAMUKKALE UNIVERSITY   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

^c Ozel Mardin Park Hastanesi ^*  (Turkey)

Author keywords

Bone morphogenic protein; Callus; Fracture; Parathyroid hormone; catenin

Indexed keywords

BETA CATENIN; BONE MORPHOGENIC PROTEIN 2 ANTIBODY; PARATHYROID HORMONE; PROTEIN ANTIBODY; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; TRANSCRIPTION FACTOR 7 LIKE 2; UNCLASSIFIED DRUG; WATER; BONE MORPHOGENETIC PROTEIN 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALLUS; CARTILAGE CELL; CONTROLLED STUDY; FEMORAL DRILL HOLE INJURY; FEMUR; FEMUR FRACTURE; FIBROBLAST; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; KIRSCHNER WIRE; MALE; MESENCHYME CELL; MOLECULAR INTERACTION; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOCYTE; PERIOSTEUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; BONE DRILL; IN VIVO STUDY; PROTEIN PROTEIN INTERACTION;

ANIMALS; BETA CATENIN; BONE MORPHOGENETIC PROTEIN 2; BONE REMODELING; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; FEMORAL FRACTURES; FEMUR; FRACTURE HEALING; INJECTIONS; MALE; PARATHYROID HORMONE; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSCRIPTION FACTORS;

EID: 84907355733     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463201402700212     Document Type: Article

References (22)

1. Urist MR, DeLange RJ, Finerman GA. Bone and cell differentiation and growth factors. Science 1983; 220:680-86. (Pubitemid 13081942)
2. Einhorn TA, Trippel SB. Growth factor treatment of fractures. Instr Course Lect 1997; 46:483-86.
3. Bostrom MPG, Camacho NP. Potential role of bone morphogenetic proteins in fracture healing. Clin Orthop 1998; 355S:274-82.
4. Opran AV, Wozney J, Csimma C, Lilly L, Riedel GE. Clinical evaluation of recombinant human bone morphogenetic Protein-2. Clin Orthop 2002; 395:110-20. (Pubitemid 34136661)
5. Fischer L, Haas AR, Tauna RS. N-Cadherin and β-Catenin involvement in BMP-2 induction of mesenchymal chondrogenesis. Signal Transduct 2001; 1-2:66-78. (Pubitemid 33757859)
6. Zhang WV, Stott NS. BMP-2-Modulated Chondrogenic Differentiation in vitro involves down-regulation of membrane-bound beta-catenin. Cell Commun Adhes2004; 11:89-91
7. Ohnakaa K, Tanabea M, Kawatea H, Nawatab H, Takayanagia R. Glucocorticoid suppresses the canonical Wnt signal in cultured human osteoblasts. Biochem Biophys Res Commun 2005; 329:177-81.
8. Salazar V, Mbalaviele G, Civitelli R. The proosteogenic action of beta-catenin requires interaction with BMP signaling, but not Tcf/Lef transcriptional activity. J Cell Biochem 2008; 104(3):942-52. (Pubitemid 351830842)
9. Zhang M, Yan Y, Lim YB, et al. BMP-2 modulates beta-catenin signaling through stimulation of Lrp5 expression and inhibition of beta-TrCP expression in osteoblasts. J Cell Biochem 2009; 108(4):896-905.
10. Nakazawaa T, Nakajimaa A, Shiomib K, Moriyaa H, Einhornc TA, Yamazakia M. Effects of low-dose, intermittent treatment with recombinant human parathyroid hormone (1-34) on chondrogenesis in a model of experimental fracture healing. Bone 2005; 37:711-19.
11. Holzer G, Majeska RJ, Lundy MW, Hartke JR, Einhorn TA. Parathyroid hormone enhances fracture healing: a preliminary report. Clin Orthop 1999; 366:258-63. (Pubitemid 29439363)
12. Guo J, Liu M, Yang D, et al. Suppression of Wnt signaling by Dkk1 attenuates PTH-mediated stromal cell response and new bone formation. Cell Metab 2010; 11(2):161-71.
13. Kulkarni NH, Halladay DL, Miles RR, et al. Effects of parathyroid hormone on Wnt signaling pathway in bone. J Cell Biochem 2005; 95(6):1178-90. (Pubitemid 41420125)
14. Kempen DH, Lu L, Hefferan TE, Creemers LB, Heijink A, Maran A, Dhert WJ, Yaszemski MJ. Enhanced bone morphogenetic Protein-2-induced ectopic and orthotopic bone formation by intermittent parathyroid hormone (1-34). Tissue Eng Part A 2010; 16(12):3769-77.
15. Kloen P, Paola M, Richmond J, Perino G, Helfet DL, Goumans MJ. BMP signaling components are expressed in human fracture callus. Bone 2003; 33:362-71. (Pubitemid 37103253)
16. Marsell R, Jonsson KB, Cho TJ, Einhorn TA, Ohlsson C, Schipani E. Mice expressing a constitutively active PTH/PTHrP receptor in osteoblasts show reduced callus size but normal callus morphology during fracture healing. Acta Orthop 2007; 78(1):39-45. (Pubitemid 46570256)
17. Tsiridis E, Morgan EF, Bancroft JM, et al. Effects of OP-1 and PTH in a new experimental model for the study of metaphyseal bone healing. J Orthop Res 2007; 25:1193-203. (Pubitemid 47365293)
18. Mbalaviele G, Sheikh S, Stains JP, Salazar VS, Cheng SL, Chen D, Civitelli R. β-Catenin and BMP-2 2 to promote osteoblast differentiation and new bone formation. J Cell Biochem 2005; 94:403-18.
19. Dong Y, Drissi H, Chen M, Chen D, Zuscik MJ, Schwarz EM, O'Kefee RJ. Wnt-mediated regulation of chondrocyte maturation: modulation by TGF-β. J Cell Biochem 2005; 951057-68.
20. Modarresi R, Lafond T, Roman-Bias JA, Danielson KD, Tuan RS, Seghatoleslam MR. N-cadherin mediated distribution of P-catenin alters MAP kinase and BMP-2 signaling on chondrogenesis-related gene expression. J Cell Biochem 2005; 95(1):53-63. (Pubitemid 41420215)
21. Tobimatsu T, Kaji H, Sowa H, Naito J, Canaff J, Hendy GN, Sugimoto T, Chihara K. Parathyroid hormone increases β-catenin levels through Smad3 in mouse osteoblastic cells. Endocrinology 2006; 147(5):2583-90.
22. Papathanasiou I, Malizos KN, Tsezou A. Bone morphogenetic protein-2-induced Wnt/β-catenin signaling pathway activation through enhanced low-density-lipoprotein receptor-related protein 5 catabolic activity contributes to hypertrophy in osteoarthritic chondrocytes. Arthritis Res Ther 2012; 14(2):R82. doi: 10.1186/ar3805.